References
1993; Wiley; Volume: 23; Issue: s3 Linguagem: Inglês
10.1111/j.1365-2222.1993.tb00387.x
ISSN1365-2222
Tópico(s)Asthma and respiratory diseases
ResumoClinical & Experimental AllergyVolume 23, Issue s3 p. 38-44 References First published: August 1993 https://doi.org/10.1111/j.1365-2222.1993.tb00387.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Aalberse R, van der Gaag R, van Leeuwen J. Serological aspects of IgG antibodies. I. Prolonged immunisation results in an IgG4-restricted response. J Immunol 1983; 130: 722–6. Anderson HR, Strachan DP. Asthma mortality in England and Wales, 1979–89. Lancet 1991; 337: 1357. Ansari AA, Shenbagamurthi P, Marsh DG. Complete primary structure of a lolium perenne (perennial rye grass) allergen Lol pIII: comparison with known Lol pI and II sequences. Biochemistry 1989a; 28: 8665–70. Ansari AA, Shenbagamurthi P, Marsh DG. Complete amino acid sequence of lolium perenne (perennial rye grass) allergen Lol pII. J Biol Chem 1989b; 264: 11181–5. Asad SI, Kemeny DM, Youlten LJ, Frankland AW, Lessof MH. Effect of aspirin in aspirin-sensitive patients. Br Med J 1984; 288: 745–8. Association of Anaesthetists of G.B. and Ireland Anaphylactic Reactions Associated with Anaesthesia. 9 Bedford Square, London WC1B 3RA, U.K. 1990. Baer H, Godfrey H, Maloney CJ, Norman PS, Lichtenstein LM. The potency and antigen E content of commercially prepared ragweed extracts. J Allergy 1970; 45: 347–54. Bierman W, van Arsdel PP. Penicillin allergy in children. J Allergy 1969; 43: 267–72. Blaauw PJ, Smithuis LOMJ. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital sting. J Allergy Clin Immunol 1985; 75: 556–62. Blainey AD, Phillips MJ, Oilier S, Davies RJ. Hyposensitization with a tyrosine adsorbed extract of Dermatophagoides pteronyssinus in adults with perennial rhinitis. Allergy 1984; 39: 521–8. Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med 1991; 324: 1785–90. Bousquet J, Calvayrac P, Guerin B, Hejjaoui A, Dhivert H, Hewitt B, Michel FB. Immunotherapy with standardized Dermatophagoides pteronissinus extract. I. In vivo and in vitro parameters after a short course of immunotherapy. J Allergy Clin Immunol 1985; 76: 734–44. Bousquet J, Fontez A, Aznar R, Robinet-Levy M, Michel FB. Combination of passive and active immunisation in honey bee venom immunotherapy. J Allergy Clin Immunol 1987; 79: 947–54. Bousquet J, Maasch HJ, Martinet B, Hejjaoui A, Wahl R, Michel FB. Double-blind placebo-controlled immunotherapy with mixed grass pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988; 82: 439–46. Bousquet J, Maasch HJ, Hejjaoui A, Skassa-Brociek W, Wahl R, Dhivert H, Michel FB. Double blind placebo-controlled immunotherapy with mixed grass pollen allergoids. III. Efficacy and safety of unfractionated and high molecular weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol 1989; 84: 546–56. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind placebo-controlled immunotherapy with mixed grass pollen allergoids. IV. Comparison of the safety of two dosages of a high molecular weight allergoid. J Allergy Clin Immunol 1990a; 85: 490–7. Bousquet J, Hejjaoui A, Michel FB. Specific immunotherapy in asthma. J Allergy Clin Immunol 1990b; 86: 292–305. Breiteneder H, Pettenburger K, Bito A, Valenta R, Kraft D, Rumpold H, Scheiner O, Breitenbach M. The gene coding for the major birch pollen allergen Bet vI is highly homologous to a pea disease resistance response gene. EM BO J 1989; 8: 1935–38. British Thoracic Association. A trial of house dust mite extract in bronchial asthma. Br J Dis Chest 1979; 73: 260–70. British Thoracic Society. Deaths from asthma in two regions of England. Br Med J 1982; 285: 1251–5. British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Guidelines for the management of asthma in adults. Br Med J 1990a; 301: 651–3. British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign Guidelines for the management of asthma in adults. II. Acute severe asthma. Br Med J 1990b; 301: 797–800. Brown LA, Goldberg ND, Shearer WT. Long term ticarcillin desensitisation by the continuous oral administration of penicillin. J Allergy Clin Immunol 1982; 69: 51–4. Brunet CV, Bedard PM, Lavoie A, Jobin M, Herbert J. Allergic rhinitis to ragweed pollen. Reassessment of the effects of immunotherapy on cellular and humoral responses. J Allergy Clin Immunol 1992; 89: 76–86. Burney PGJ. Asthma mortality in England and Wales: evidence for a further increase. Lancet 1986; 2: 323–6. Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children Br Med J 1990; 300: 1306–10. Burr ML, Butland BK, King S, Vaughan Williams E. Changes in asthma prevalence: two surveys fifteen years apart. Arch Dis Child 1989; 96: 1452–6. Caranosos CJ, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalization. JAMA 1974; 228: 713–17. Chapman MD, Heymann PW, Wilkins SR, Brown J, Platts-Mills TAE. Monoclonal immunoassays for the major dust mite (Dermatophagoides) allergens, Der pI and Der fI, and quantitative analysis of the allergen content of mite and house dust extracts. J Allergy Clin Immunol 1987; 80: 184–94. Chua KY, Stewart GA, Thomas WR, Simpson RJ, Dilworth RJ, Plozza TM, Turner KJ. Sequence analysis of cDNA coding for a major house dust mite allergen Der pI: homology with cysteine proteases. J Exp Med 1988; 167: 175–82. Cockcroft DW, Hargreave FE, Dolovich J. Intranasal beclomethasone dipropionate in rhinitis. In: N Mygind, TJH Clark, eds. Topical Steroid Treatment for Asthma and Rhinitis. London : Balliere Tindall, 1980. Committee on the Safety of Medicines. CSM update: Desensitizing vaccines. Br Med J 1986; 293: 948. Corrado OJ, Pastorello E, Oilier S, Cresswell L, Zanussi C, Ortolani C, Incovaia A, Fugazza A, Lovely JR, Harris RI, Watson HK, Davies RJ. A double-blind study of hyposensitisation with an alginate conjugated extract of D. pteronyssinus‘Conjuvac’ in patients with perennial rhinitis. Allergy 1989; 44: 108–15. Creticos P, van Metre TE, Mardingley MR, Rosenberg GL, Adkinson NF. Dose-response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol 1984; 73: 94–104. Creticos P, Adkinson NF, Kagey-Sobotka A, Proud D, Meier HL, Naclerio RM, Lichtenstein LM, Norman PS. Nasal challenge with ragweed pollen in hayfever patients. Effect of immunotherapy. Clin Invest 1985; 76: 2247–53. D'Souza MF, Pepys J, Wells ID, Tai E, Palmer F, Overell BG, McGrath IT, Megson M. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy. A controlled study of clinical and immunological effects. Clin Allergy 1973; 3: 177–93. DeSwarte RD. Drug allergy: an overview. Clin Rev Allergy 1986; 4: 143–69. Devey ME, Lee SR, Richards D, Kemeny DM. Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee venom immunotherapy. J Allergy Clin Immunol 1989; 84: 326–30. Devey ME, Wilson DV, Wheeler AW. The IgG subclasses of antibodies to grass pollen produced in hay fever patients during hyposensitization. Clin Allergy 1976; 6: 227–36. Djurup R, Mailing HJ. High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens. Clin Allergy 1987; 17: 459–68. Dreborg S, Frew AJ. Revised EAACI position paper on allergen standardization and skin tests. Allergy 1993; 48(S14). Dreborg S. Position paper on skin tests in Type I hypersensitivity. Allergy 1989a; 44(S10). Dreborg S. Skin tests used for standardization of allergenic preparations. Allergy 1989b; 44(S10): 38–46. Dreborg S, Agrell B, Foucard T, Kjellman NM, Koivikko A, Nilsson S. A double-blind, multicenter immunotherapy trial in children using a purified and standardized Cladosporium herbarum preparation. Clinical results allergy 1986; 41: 131–40. Dreborg S, Einarsson R. The major allergen content of allergen extracts reflects their biological activity. Allergy 1992; 47: 418–23. Durham SR, Varney VA, Gaga M, Frew AJ, Jacobson M, Kay AB. Immunotherapy and allergic inflammation. Clin Exp Allergy 1991; 21(S1): 206–10. Ewan PW. Clinical features, natural history and immunological studies in insect sting allergy. Q J Med 1984; 52: 542–3. Ewan PW. Allergy to insect stings: a review. J Roy Soc Med 1985; 78: 234–9. Ewan PW. Allergen immunotherapy. CurrOpin Immunol 1989; 1: 672–8. Ewan PW, Alexander MM, Snape C, Ind PW, Agrell B. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy 1988a; 18: 501–8. Ewan PW, Laveile BM, Snape C, Alexander MA, Agrell B, Dreborg S. An analysis of reactions to three house dust mite desensitization regimes. Allergy 1988b; 43 (Suppl 7): 43 (abstr). Ewan PW, McHugh SM, Romero C. Defective interferon-gamma production in house dust mite allergy. Clin Allergy 1990; 20(S1): 50. Ewan PW, Deighton J, Wilson AB, Lachmann PJ. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin Exp Allergy 1993a (in press). Ewan PW et al. Rush induction of venom immunotherapy: clinical observations and studies on the mechanisms 1993 (manuscript in preparation). Ewan PW, Stewart AG. A prospective study of systemic reactions to venom immunotherapy. Clin Exp Allergy 1993; 23 (S1): 82. Executive Committee American Academy of Allergy and Immunology Position Statement. Personnel and equipment to treat systemic reactions caused by immunotherapy with allergic extracts. J Allergy Clin Immunol 1986; 77: 271–3. Executive Committee American Academy of Allergy and Immunology. Beta-adrenergic blockers, immunotherapy, and skin testing. J Allergy Clin Immunol 1989; 84: 129–30. Executive Committee American Academy of Allergy and Immunology. The waiting period after allergen skin testing and immunotherapy (position statement). J Allergy Clin Immunol 1990; 85: 526–7. Fisher M. Treating anaphylaxis with sympathomimetic drugs. Br Med J 1992; 305: 1107–8. Fontana VJ, Holt LE, Mainland D. Effectiveness of hyposensitization therapy in ragweed hay fever in children. J Am Med Assoc 1966; 195: 985–9. Ford RPK, Davison KP. Is there a place for bee venom desensitization in children. Aust NZ J Med 1987; 17: 85–91. Ford A, Seagroatt V, Platts-Mills TAB, Lowenstein H. A collaborative study of the first international standard of Dermatophagoides pteronyssinus (house dust mite) extract. J Allergy Clin Immunol 1985; 75: 676–86. Frankland AW, Augustin R. Prophylaxis of summer hayfever and asthma. A controlled trial comparing crude grass pollen extracts with the isolated main protein component. Lancet 1954; 1: 1055–7. Freeman J. Vaccination against hay fever: report of results during the first three years. Lancet 1914; 1: 1178. Frew AJ, Kay AB. The relationship between infiltrating CD4 + lymphocytes, activated eosinophils and the magnitude of the allergen-induced late-phase cutaneous reaction. J Immunol 1988; 141: 4158–64. Frostad AB, Grimmer OSL, Moxnes A, Aas K. Clinical effects of hyposensitization using a purified allergen preparation from timothy pollen as compared to crude aqueous extracts from timothy pollen and a 4 grass pollen mixture. Clin Allergy 1983; 13: 337–57. Furin MJ, Norman PS, Creticos PS, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Immunotherapy decreases antigen-induced eosinophil migration into the nasal cavity. J Allergy Clin Immunol 1991; 98: 27–32. Gaddie J, Skinner C, Palmer KNV. Hyposensitization with house dust mite vaccine in bronchial asthma. Br Med J 1976; 2: 561–2. Gillman SA, Cummins LH, Kozak PP, Hoffman DR. Venom immunotherapy: comparison of ‘rush’ vs ‘conventional’ schedules. Ann Allergy 1980; 45: 351–4. Golden DBK, Meyers DA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Clinical relevance of the venom-specific IgG antibody level during immunotherapy. J Allergy Clin Immunol 1982; 69: 489–93. Golden DBK, Valentine MD, Kagey-Sobotka A, Lichtenstein LM. Regimens of hymenoptera venom immunotherapy. Ann Intern Med 1981; 92: 620–4. Graft DF, Schuberth KC, Kagey-Sobotka A, Kwiterovich KA, Niv Y, Lichtenstein LM, Valentine MD. A prospective study of the natural history of large local reactions after hymenoptera stings in children. J Pediatr 1984; 104: 664–8. Green GR, Rosenblum AH, Sweet LC. Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. J Allergy Clin Immunol 1977; 54: 19–28. Griffith IJ, Smith PM, Pollock J, et al. cDNA cloning and sequencing of cat allergen Fel dI. Proc Natl Acad Sci USA 1992 (in press). Hedlin G, Graff-Lonnevig V, Heilborn H, Lilja G, Norrlind K, Pegelow KO, Sundin B, Lowenstein H. Immunotherapy with cat and dog dander extracts. II. In vivo and in vitro immunological effects observed in a 1 year double blind placebo study. J Allergy Clin Immunol 1986; 77: 488–96. Hedlin G, Silber G, Naclerio RM, Proud D, Lamas AM, Eggleston P, Adkinson NF. Comparison of the in vivo and in vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy 1990; 20: 491–500. Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990; 85: 473–9. Hejjaoui A, Ferrando R, Dhivert H, Michel FB, Bousquet J. Systemic reactions occurring during immunotherapy with standardized pollen extracts. J Allergy Clin Immunol 1992; 89: 925–33. Helm RM, Gauerke MB, Baer H, Lowenstein H, Ford A, Levy DA, Norman PS, Yunginger JW. Production and testing of an international reference standard of short ragweed pollen extract. J Allergy Clin Immunol 1984; 73: 790–800. Hepner MJ, Ownby DR, Anderson JA, Rowe MS, Sears-Ewald D, Brown EB. Risks of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. J Allergy Clin Immunol 1990; 86: 407–11. Hill DJ, Hosking CS, Shelton MJ, Turner MW. Failure of hyposensitization in treatment of children with grass-pollen asthma. Br Med J 1982; 284: 306–9. Horst M, Hejjaoui A, Horst V, et al. Double-blind, placebo-controlled rush immunotherapy with a standardized alternaria extract. J Allergy Clin Immunol 1990; 85: 460–72. Huang SK, Zwollo P, Marsh DG. Class II MHC restriction of human T-cell responses to ragweed allergens: Amb a V homologues. Eur J Immunol 1991; 21: 1469–73. Hunt KJ, Valentine MD, Kagey-Sobotka A, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299: 157–61. Iliopoulos O, Proud D, Adkinson NF, Creticos PS, Norman PS, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effects of immunotherapy on the early, late and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991; 87: 855–66. International Paediatric Consensus Group. Asthma: a follow-up statement from an international consensus group. Arch Dis Child 1992; 67: 240–8. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children. A 14 year study. Pediatrics 1968; 42: 793. Juniper EF, Kline PA, Ramsdale EH, Hargreave FE. Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection immunotherapy (Pollinex-R) in the treatment of seasonal allergic rhinocon-junctivitis. J Allergy Clin Immunol 1990; 85: 606–11. Kaad PH, Ostergaard PA. The hazard of mould hyposensitization in children with asthma. Clin Allergy 1982; 12: 317–20. Kampelmacher MJ, van der Zwan JC (1987) Provocation test with a living insect as a diagnostic tool in systemic reactions to bee and wasp venom: a prospective study with emphasis on the clinical aspects. Clin Allergy 1987; 17: 317–27. Kay AB, Ying S, Varney V, Gaga M, Surham SR, Moqbel R, Wardlaw AJ, Hamid Q. Messenger RNA expression of the cytokine gene cluster IL-3, IL-4, IL-5 and GM-CSF in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775–8. Kemeny DM, Mackenzie-Mills M, Harries MG, Youlten LJF, Lessof MH. Antibodies to purified bee venom proteins and peptides. II. A detailed study of the changes in IgE and IgG antibodies to individual bee venom antigens. J Allergy Clin Immunol 1983; 72: 376–85. Kerr JW, Murchison LE. A controlled trial of pollen adsorbate in the treatment of hayfever. Scott Med J 1963; 8: 485. Lessof MH. Anaphylaxis. Prescribers Journal 1989; 29: 91–5. Lessof MH, Kagey-Sobotka A, Lichtenstein LM. Effects of passive antibody in bee venom anaphylaxis. J Hopk Med J 1978; 142: 1–7. Lichtenstein LM. Histamine releasing factors and IgE heterogeneity. J Allergy Clin Immunol 1988; 81: 814–20. Lichtenstein LM, Norman PS, Winkenwerder WL. A single year of immunotherapy for ragweed hayfever: immunologic and clinical studies. Ann Intern Med 1971; 75: 663–71. Lichtenstein LM, Valentine MD, Sobotka AK. Insect allergy: the state of the art. J. Allergy Clin Immunol 1979; 64: 5–12. Lind P, Weeke B, Lowenstein H. A reference allergen preparation of the house dust mite D. pteronyssinus, produced from whole mite culture. Allergy 1984; 39: 259–74. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987; 79: 660–7. Løwenstein H. Domestic allergens. In: JW Kerr, ed. Proceedings of the XI International Congress of Allergology and Clinical Immunology. London : Macmillan 1983; 545–8. Løwenstein H, Ipsen H, Lind P, Matthiesen F. The physicochemical and biological characteristics of allergens. In: M Lessof, T Lee, M Kemeny eds. Allergy. New York : John Wiley 1987; 87–104. Lø wenstein H, Marsh DG. Antigens of Ambrosia elatior (short. ragweed) pollen. I. Crossed immunoelectrophoresis. J Immunol 1981; 126: 2501–3. Lø wenstein H, Matthiesen F, Ipsen H. Preparation and standardization of allergen extracts. In: RFA Lockey, ed. Allergen Immunotherapy. New York : Marcel Dekker 1991; 161–70. Lumry WR, Curd JG, Zeiger RS, Pleskow WW, Stevenson DD. Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol 1983; 71: 580–7. Maasch HJ, Marsh DG. Standardized extracts: modified allergens—allergoids. Clin Rev Allergy 1987; 5: 89–106. Mailing HJ. Immunotherapy position paper. Allergy 1988; 43(S6): 1–33. Mailing HJ, Bjornsten J. Safety of routine immunotherapy (abstract). Allergy 1992; 47(S12). Mailing HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium. Allergy 1986; 41: 507–19. Mailing HJ, Stahl-Skov P. Diagnosis and immunotherapy of mould allergy. VIII. Qualitative and quantitative estimation on IgE in Cladosporium immunotherapy. Allergy 1988; 43: 228–38. Mailing HJ, Weeke B. Revised EAACI position paper on immunotherapy. Allergy 1993; 48(S14). Marsh DG, Lichtenstein LM, Campbell DH. Studies on ‘allergoids’ prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology 1970; 18: 705–22. Marsh DG, Norman PS, Roebber M, Lichtenstein LM. Studies on ‘allergoids’ prepared from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J Allergy Clin Immunol 1981; 68: 449–59. Mauriello PM, Barde SH, Georgilis JW, Resiman RE. Natural history of large local reactions from stinging insects. J Allergy Clin Immunol 1984; 74: 494–8. McHugh SM, Ewan PW. Reduction of increased serum neutrophil activity following effective hyposensitisation in house dust mite allergy. Clin Exp Allergy 1989; 19: 327–34. McHugh SM, Lavelle B, Kemeny DM, Patel S, Ewan PW. A placebo-controlled trial of immunotherapy with two extracts of D. pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG and IgG subclasses. J Allergy Clin Immunol 1990; 86: 521–32. McHugh SM, Ewan PW. A clinical index: a new method of assessing efficacy of allergen immunotherapy. Allergy 1992; 47: 115–20. McKenzie MW, Marchall GL, Netzloff ML, Cluff LE. Adverse drug reactions leading to hospitalization in children. J Pediatr 1976; 89: 487–90. Miller RR. Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1974; 134: 219–23. Miller RR, Greenblatt DJ. Drug Effects in Hospitalized Patients. Chichester : John Wiley & Sons 1976. Moellering RC, Swartz MN. Drug therapy. The new cephalo-sporins. N Engl J Med 1976; 294: 24–8. Mosbech H, Mailing HJ, Biering I, Bowadt H, Soborg M, Weeke B, Lowenstein H. Immunotherapy with yellow jacket venom. A comparative study including three different extracts: one adsorbed to aluminium extract and two unmodified. Allergy 1986; 41: 95–103. Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988; 43: 523–9. Mosbech H, Weeke B. Does immunotherapy have a role in the treatment of asthma Clin Allergy 1986; 16: 10–16. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL. Two types of murine helper T-cell clone. J Immunol 1986; 136: 2348–57. Müller UR. Insect sting allergy: clinical picture, diagnosis and treatment. Stuttgart : Gustav Fischer Verlag, 1990. Müller U, Thurnheer U, Patrizzi R, Spiess RHR. Immunotherapy in bee sting hypersensitivity. Bee venom versus whole body extract. Allergy 1979; 34: 369–78. Müller UR, Morris T, Bischof M, Friedli H, Sharvil F. Combined active and passive immunotherapy in honey bee sting allergy. J Allergy Clin Immunol 1986; 78: 115–22. Müller U, Helbling A, Bischof M. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy 1989; 44: 412–18. Müller U, Heibling A, Berchtold E. Are there differences between hypersensitivity to honeybee venom and to vespula venom. J Allergy Clin Immunol 1990; 85:21 l(abst). Murray AB, Ferguson AC, Morrison BJ. Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy. Ann Allergy 1985; 54: 541–4. Naclerio RM, Mizrahi EA, Adkinson NF. Immunologic observations during desensitisation and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 1983; 71: 294–301. Nagaya H. Induction of antigen-specific suppressor cells in patients with hay fever receiving immunotherapy. J Allergy Clin Immunol 1985; 75: 388–94. Nakagawa T, Takaishi T, Sakamoto Y, Ito K, Miyamoto T, Skvaril F. IgG4 antibodies in patients with house dust mite-sensitive bronchial asthma: relationship with antigen-specific therapy. Int Arch Allergy Appl Immunol 1983; 71: 122–5. Nakagawa T, Kozeki H, Katagiri J, Fujita Y, Yamashita N, Miyamoto T, Skvaril F. Changes of house dust mite-specific IgE, IgG and IgG subclass antibodies during immuno-therapy in patients with perennial rhinitis. Int Arch Allergy Appl Immunol 1987; 82: 95–9. Nataf P, Guinnepain MT, Herman D. Rush venom immuno-therapy: a 3 day programme for hymenoptera and sting allergy. Clin Allergy 1984; 14: 269–75. Nedergaard-Larsen J, Ford A, Gjesing B, Levy D, Petrunov B, Silvestri L, Lowenstein H. The collaborative study of the first international standard of a dog (Canis domesticus) hair/ dander extract. J Allergy Clin Immunol 1988; 82: 318–30. NIH International Consensus Report Report on diagnosis and treatment of asthma. US Department of Health and Human Services, National Institutes of Health 1992. Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys. Br Med J 1992; 304: 873–5. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1: 1572. Norman PS. International units. In: R Kurth, ed. Regulatory Control and Standardization of Allergenic Extracts. Arbei-ten aus dem Paul-Erhlich-Institut. Stuttgart : Gustav Fischer Verlag, 1988; 45–50. Norman PS, van Metre TE. The safety of allergenic immunotherapy. J Allergy Clin Immunol 1990; 86: 522–5. O'Hehir RE, Young DB, Kay AB, Lamb JR. Cloned human T-lymphocytes reactive with Dermatophagoides farinae (house dust mite): a comparison of T- and B-cell recognition. Immunology 1987; 62: 635–40. O'Hehir RE, Frew AJ, Eckels DD, Kay AB, Lamb JR. MHC class II restriction specificity of cloned human T-lymphocytes reactive with Dermatophagoides farinae (house dust mite). Immunology 1988; 64: 627–31. O'Hehir RE, Aguilar BA, Schmidt TJ, Gollnick SO, Lamb JR. Functional inactivation of Dermatophagoides spp. (house dust mite) reactive human T-cell clones. Clin Exp Allergy 1991; 21: 209–15. Ohman JL. Allergen immunotherapy in asthma: evidence for efficacy. J Allergy Clin Immunol 1989; 84: 133–9. Ohman JL, Findlay SR, Leitermann KM. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol 1984; 74: 230–9. Ortolani C, Pastorello E, Moss RB, Hsu YP, Restuccia M, Joppolo G, Miadonna A, Correlli U, Halpern G, Zanussi C. Grass pollen immunotherapy: a single year double-blind placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunol 1984; 73: 283–9. Otsuka H, Mezawa A, Ohnishi K, Okubo K, Seki H, Okuda M. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991; 21: 115–19. Parker CW. Drug allergy (three parts). N Engl J Med 1975; 292:511–14, 732–6, 957–60. Parker CW, Shapiro J, Kern M, Eisen HN. Hypersensitivity to pencillin and derivatives in human beings with penicillin allergy. J Exp Med 1962; 115: 821–38. Parronchi P, Macchia D, Piccinni MP, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnani S. Allergen and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991; 88: 4538–42. Pauli G, Bessot JC, Bigot H, et al. Clinical and immunologic evaluation of hyposensitization with tyrosine-adsorbed Dermatophagoides pteronyssinus extract: a double-blind placebo-controlled trial. Clin Allergy 1984; 14: 209–19. Perez M, Ishioka GY, Walker LE, Chesnut R. cDNA cloning and immunological characterization of the rye grass allergen Lol pI. J Biol Chem 1990; 265: 16210–15. Petz LD. Immunologic reactions of humans to cephalosporins. Postgrad Med J 1971; 47: 864–9. Petz LD. Immunologic cross reactivity between penicillins and cephalosporins: a review. J Infect Dis 1978; 137: 874–9. Platts-Mills TAB. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 1979; 122: 2218–25. Platts-Mills TAB, Chapman MD. Allergen standardization. J Allergy Clin Immunol 1991; 87: 621–5. Price JF, Warner JO, Hey EN, Tuner MW, Soothill JF. A controlled trial of hyposensitization with tyrosine-adsorbed Dermatophagoides pteronyssinus antigen in childhood asthma. In vivo aspects. Clin Allergy 1984; 14: 209–19. Rackemann FM, Edwards MC. Asthma in children: a follow up study of 688 patients after an interval of twenty years. N Eng J Med 1952; 256: 815–63. Rak S, Haakanson L, Venge P. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during the pollen season. J Allergy Clin Immunol 1990; 86: 706–13. Rak S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988; 82: 470–80. Rawle FC, Mitchell EB, Platts-Mills TAE. T cell responses to the major allergens from the house dust mite Dematopha-goides pteronyssinus, antigen P1: comparison of patients. J Immunol 1984; 133: 195–201. Rawlins MD, Wood SM, Mann RD. Hazards with desensitizing vaccines. Arb Paul Ehrlich Inst 1988; 82: 147–51. Reid MJ, Moss RB, Yao-Pi Hsa MS, Kwasnicki JC, Commer-ford TM, Nelson BL. Seasonal asthma in northern California. Allergic causes and efficacy of immunotherapy. J Allergy Clin Immunol 1986; 78: 590–600. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TAE. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1990; 85:180(abst). Reid MJ, Lockey RF, Turkeltaub P, Platts-Mills TAE, Lehrer SB. Fatalities from Immunotherapy 1990–91. J Allergy Clin Immunol 1992; 89:Abst no. 823. Rocklin RE, Sheffer AL, Greineder DR, Melmon KL. Generation of antigen-specific suppressor cells during allergy desensitisation. N Engl J Med 1980; 302: 1213–19. Rogers BL, Morgenstern JP, Griffith IJ, Yu XB, Counsell CM, Brauer AW, King TP, Garwas RD, Kuo MC. Complete sequence of the allergen Amb all: recombinant expression and reactivity with T-cells from ragweed-allergic patients. J Immunol 1991; 147: 2547–52. Rothbard JB, Gefter ML. Interaction between immunogenic peptides and MHC proteins. Ann Rev Immunol 1991; 9: 527–65. Royal College of Physicians Allergy: Conventional and Alternative Concepts. London : RCP, 1992. Sadan N, Rhyne MB, Mellits ED, Golstein EO, Levy DA, Lichtenstein LM. Immunotherapy for pollinosis in children. Investigation of the immunologic basis of clinical improvement. N Engl J Med 1969; 280: 623–7. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987; 107: 204–15. Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986; 16: 483–91. Schou C, Hansen GN, Lintner T, Lowenstein H. Assay for the major dog allergen, Can fI: investigation of house dust samples and commercial dog extracts. J Allergy Clin Immunol 1991; 88: 847–53. Schuberth KC, Lichtenstein LM, Kagey-Sobotka A, Szklo M, Kwiterovich KA, Valentine MD. Epidemiologic study of insect allergy in children. II. Effect of accidental stings in allergic children. J Pediatr 1983; 102: 361–5. Settipane GA, Chafee FH. Natural history of allergy to hymenoptera. Clin Allergy 1979; 9: 385–90. Silvanovich A, Astwood J, Zhang L, Olsen E, Kisil F, Sehon A, Mohapatra S, Hill R. Nucleotide sequence analysis of three cDNAs coding for Poa pIX isoallergens of Kentucky bluegrass pollen. J Biol Chem 1991; 266: 1204–10. Sobotka AK, Valentine MD, Ishizaka K, Lichtenstein LM. Measurement of IgG blocking antibodies: development and application of a radioimmunnoassay. J Immunol 1976; 117: 84–90. Soloway P, Fish S, Passmore H, Gefter M, Coffee R, Manser T. Regulation of the immune response to peptide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structures or MHC haplotype. J Exp Med 1991; 174: 847–58. Stark HS, Earle GN, Gross GN et al. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. J Allergy Clin Immunol 1987; 79: 523–32. Stevenson DD, Pleskow WW, Simon RA, Mathison DA, Lumry WR, Schatz M, Zeiger RS. Aspirin-sensitive rhino-sinusitis and asthma: a double blind cross-over study of treatment with aspirin. J Allergy Clin Immunol 1984; 73: 500–7. Sullivan TJ, Wedner HJ, Shatz GS, Yecies LD, Parker CW. Skin testing to detect penicillin allergy. J Allergy Clin Immunol 1981; 68: 171–7. Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner HJ. Desensitisation of patients allergic to penicillin using orally administered β-lactam antibiotics. J Allergy Clin Immunol 1982; 69: 275–80. Sundin B, Lilja G, Graff-Lonnevig V, Hedlin G, Heilborn H, Norrlind K, Peglow KO, Lowenstein H. Immunotherapy with partially purified and standardized animal dander extracts. 1. Clinical results from a double-blind study on patients with animal dander asthma. J Allergy Clin Immunol 1986; 77: 478–87. Tamir R, Levy I, Duer S, Pick AL. Immediate adverse reactions to immunotherapy in allergy. Allergy 1992; 47: 260–3. Taudorf E, Laursen LC, Lanner A, Bjorksten B, Dreborg S, Soborg M, Weeke B. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987; 80: 153–61. Thoburn R, Johnson JE, Cluff LE. Studies on the epidemiology of adverse drug reactions. IV. The relationship of cephalothin and penicillin allergy. JAMA 1966; 198: 345–8. Thompson RA, Bousquet J, Cohen S, Frei PC, Jager L, Lambert PH, Lessof MH, Loblay RH, Mailing HJ, Norman PS, De Week AL, Weeke B. Current status of allergen immunotherapy. Lancet 1986; 1: 259–61. Turkeltaub PC. Biological standardization of allergenic extracts. Allergol Immunopathol 1989; 17: 53–65. Urbanek R, Kemeny DM, Richards D. Subclass of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long term protection from bee stings and following termination of venom immunotherapy. Clin Allergy 1986; 16: 317–22. Valentine MD, Schuberth KC, Kagey-Sobotka A, Graft DF, Kwiterovich KA, Szklo M, Lichtenstein LM. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990; 323: 1601–3. Van Bever HP, Bosmans J, De Clerk LS, Stevens WJ. Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen. Allergy 1988; 43: 378–85. van der Zwan JC. Anaphylactic reactions to bee or wasp stings: results of 308 sting provocations. Schweiz Med Wschr 1991; 121 (S40/I): 62. van der Giessen M, Homan WL, van Kernbeek G, Aalberse RC, Dieges PH. Subclass typing of IgG antibodies formed by grass pollen allergic patients during immunotherapy. Int Arch Allergy Appl Immunol 1976; 50: 625–40. van Metre TE, Marsh DG, Adkinson NF, et al. Immunotherapy for cat asthma. J Allergy Clin Immunol 1988; 82: 1053–8. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by anti-allergic drugs. Br Med J 1991; 302: 265–9. Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, Kay AB, Durham SR. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993 (in press). Viander M, Koivikko A. The seasonal symptoms of hyposensitized and untreated hayfever patients in relation to birch pollen counts: correlations with nasal sensitivity, prick tests and RAST. Clin Allergy 1978; 8: 387–96. Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978; 2: 912–15. Warner JO. Hyposensitization in asthma: a review. J Roy Soc Med 1981; 74: 60–5. Warrington RJ, Simons FE, Ho HW, Gorski BA. Diagnosis of penicillin allergy by skin testing: the Manitoba experience. Can Med Assoc J 1978; 118: 787–9. WHO Guidelines for the preparation and establishment of reference materials and reference reagents for biological substances. WHO Technical Report Series, 1978; 626. Whyte J, Greenan E. Drug usage and adverse reactions in paediatric patients. Acta Paediatr Scand 1977; 66: 767–75. Wierenga EA, Snoek M, de Groot C, Chretien I, Bos JD, Jansen HM et al. Evidence for compartmentalisation of functional subsets of CD4+ T-lymphocytes in atopic subjects. J Immunol 1990; 144: 4651–6. Yunginger JW, Squillance DM, Helm RM. IUIS criteria for reference preparations. Arb Paul Ehrlich, Inst 1988; 82: 129–35. Zeiss CR, Metzger WJ, Levitz D. Quantitative relationship between IgE antibody and blocking antibodies specific for antigen E in patients given immunotherapy with ragweed antigen E. Clin Exp Immunol 1977; 28: 250–51. Volume23, Issues3August 1993Pages 38-44 ReferencesRelatedInformation
Referência(s)